Structural highlights
Function
Q7MJG0_VIBVY
Publication Abstract from PubMed
Type I restriction-modification enzymes are oligomeric proteins composed of methylation (M), DNA sequence-recognition (S), and restriction (R) subunits. The different bipartite DNA sequences of 2-4 consecutive bases are recognized by two discerned target recognition domains (TRDs) located at the two-helix bundle of the two conserved regions (CRs). Two M-subunits and a single S-subunit form an oligomeric protein that functions as a methyltransferase (M(2)S(1) MTase). Here, we present the crystal structure of the intact MTase from Vibrio vulnificus YJ016 in complex with the DNA-mimicking Ocr protein and the S-adenosyl-L-homocysteine (SAH). This MTase includes the M-domain with a helix tail (M-tail helix) and the S(1/2)-domain of a TRD and a CR alpha-helix. The Ocr binds to the cleft of the TRD surface and SAH is located in the pocket within the M-domain. The solution- and negative-staining electron microscopy-based reconstructed (M(1)S(1/2))(2) structure reveals a symmetric (S(1/2))(2) assembly using two CR-helices and two M-tail helices as a pivot, which is plausible for recognizing two DNA regions of same sequence. The conformational flexibility of the minimal M(1)S(1/2) MTase dimer indicates a particular state resembling the structure of M(2)S(1) MTases.
Structural features of a minimal intact methyltransferase of a type I restriction-modification system.,Seo PW, Hofmann A, Kim JH, Hwangbo SA, Kim JH, Kim JW, Huynh TYL, Choy HE, Kim SJ, Lee J, Lee JO, Jin KS, Park SY, Kim JS Int J Biol Macromol. 2022 May 31;208:381-389. doi: , 10.1016/j.ijbiomac.2022.03.115. Epub 2022 Mar 23. PMID:35337914[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Seo PW, Hofmann A, Kim JH, Hwangbo SA, Kim JH, Kim JW, Huynh TYL, Choy HE, Kim SJ, Lee J, Lee JO, Jin KS, Park SY, Kim JS. Structural features of a minimal intact methyltransferase of a type I restriction-modification system. Int J Biol Macromol. 2022 May 31;208:381-389. PMID:35337914 doi:10.1016/j.ijbiomac.2022.03.115